Clinical trial
A Pilot Study of 13Carbon-Based Deep Labeling of Bone Marrow Cells to Map Their Utilization of Extracellular Metabolites
NCT07057583 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of 13Carbon-Based Deep Labeling of Bone Marrow Cells to Map Their Utilization of Extracellular Metabolites
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- February 1, 2025
- Completion date
- December 31, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
monoclonal gammopathy of undetermined significance (mgus), non-igm monoclonal gammopathy of undetermined significance